STS 2021 Online: Congenital: Transplant/VAD
This session will highlight research into VAD support and ongoing challenges with congenital heart transplantation.
*Unless otherwise noted, speakers have nothing to disclose.
Moderators
Reshma Biniwale and Ronald Woods (Commercial Relationships: OperVu; Ownership Interest)
Presentations:
1. Banding for DCM - Iki Adachi
(Commercial Relationships: Abbott: Consultant Advisory/Board; Jarvik Inc., Consultant Advisory/Board; Medtronic; Consultant Advisory/Board)
2. The Genetically Engineered Heart as a Bridge to Allotransplantation in Infants: Just Around the Corner? - David Cleveland
3. Long-term Outcomes of Heart Transplantation in Children with Chromosomal Anomalies - Horacio Carvajal
4. Novel Atrial Cannulation for Restrictive Cardiomyopathy - Katsuhide Maeda
(Commercial Relationships: Berlin Heart Company: Consultant Advisory/Board; Heartware company; Consultant Advisory/Board)
5. Pediatric Heart Retransplantation: Outcomes and Risk Factors - Dathe Benissan-Messan
6. Panel Discussion
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Price
This session will highlight research into VAD support and ongoing challenges with congenital heart transplantation.
*Unless otherwise noted, speakers have nothing to disclose.
Moderators
Reshma Biniwale and Ronald Woods (Commercial Relationships: OperVu; Ownership Interest)
Presentations:
1. Banding for DCM - Iki Adachi
(Commercial Relationships: Abbott: Consultant Advisory/Board; Jarvik Inc., Consultant Advisory/Board; Medtronic; Consultant Advisory/Board)
2. The Genetically Engineered Heart as a Bridge to Allotransplantation in Infants: Just Around the Corner? - David Cleveland
3. Long-term Outcomes of Heart Transplantation in Children with Chromosomal Anomalies - Horacio Carvajal
4. Novel Atrial Cannulation for Restrictive Cardiomyopathy - Katsuhide Maeda
(Commercial Relationships: Berlin Heart Company: Consultant Advisory/Board; Heartware company; Consultant Advisory/Board)
5. Pediatric Heart Retransplantation: Outcomes and Risk Factors - Dathe Benissan-Messan
6. Panel Discussion